Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Moodys
Harvard Business School
QuintilesIMS
Fuji
Cipla
Cantor Fitzgerald
McKinsey
Johnson and Johnson

Generated: July 22, 2018

DrugPatentWatch Database Preview

Betamethasone sodium phosphate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for betamethasone sodium phosphate and what is the scope of betamethasone sodium phosphate patent protection?

Betamethasone sodium phosphate
is the generic ingredient in two branded drugs marketed by Watson Labs and Schering, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone sodium phosphate.
Summary for betamethasone sodium phosphate
Synonyms for betamethasone sodium phosphate
(11|A,16|A)-9-Fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)pregna-1,4-diene-3,20-dione Sodium Salt
124681-EP2295426A1
124681-EP2295427A1
151-73-5
360-63-4 (parent)
7BK02SCL3W
9-Fluoro-11|A,17,21-trihydroxy-16|A-methylpregna-1,4-diene-3,20-dione 21-(Dihydrogen Phosphate) Sodium Salt
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-(disodium phosphate)
AC-2162
AC1L23BP
AKOS015896371
B4110
Bentelan
beta-Methasone disodium phosphate
beta-Methasone phosphate
beta-Methasone sodium phosphate
beta-Methasone, disodium phosphate
betamethason sodium phosphate
Betamethasone 21-disodium phosphate
Betamethasone 21-phosphate disodium
Betamethasone 21-phosphate disodium salt
Betamethasone 21-phosphate disodium, >=97%
Betamethasone 21-phosphate sodium
Betamethasone 21-phosphate sodium salt
Betamethasone disodium phosphate
Betamethasone sodium phosphate (JP17/USP)
Betamethasone Sodium Phosphate [USAN:BAN:JAN]
Betamethasone sodium phosphate [USP:JAN]
Betamethasone sodium phosphate, European Pharmacopoeia (EP) Reference Standard
Betamethasone sodium phosphate, United States Pharmacopeia (USP) Reference Standard
Betamethazone disodium phosphate
Betnesol
C22H28FO8P.2Na
CAS-151-73-5
Celestone Phosphate
Celestone Phosphate Injection
CHEBI:3078
CHEMBL1200762
CTK8F8105
D00972
DISODIUM (1R,2S,10S,11S,13S,14R,15S,17S)-1-FLUORO-14,17-DIHYDROXY-2,13,15-TRIMETHYL-14-[2-(PHOSPHONATOOXY)ACETYL]TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-5-ONE
disodium [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
disodium 9-fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate
Disodium betamethasone 21-phosphate
disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
DSSTox_CID_27137
DSSTox_GSID_47137
DSSTox_RID_82144
DTXSID8047137
Durabetason
EINECS 205-797-0
FT-0653074
I06-1962
J-008838
Linolosal
Linosal
LS-118472
MFCD00200361
NCGC00256717-01
NSC 90616
PL046834
PLCQGRYPOISRTQ-LWCNAHDDSA-L
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 21-(dihydrogen phosphate), disodium salt
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-,21-(dihydrogen phosphate), disodium salt
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl-, 21-(dihydrogen phosphate), disodium salt
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl-, 21-(dihydrogen phosphate), disodium salt (8CI)
SCHEMBL8418
Steronema
Tox21_302467
UNII-7BK02SCL3W
Vista-Methasone

US Patents and Regulatory Information for betamethasone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering CELESTONE betamethasone sodium phosphate INJECTABLE;INJECTION 017561-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs BETAMETHASONE SODIUM PHOSPHATE betamethasone sodium phosphate INJECTABLE;INJECTION 085738-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Moodys
Johnson and Johnson
US Department of Justice
Cipla
Federal Trade Commission
Citi
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.